New pathways identified to reduce pain and depressive symptoms associated with fibromyalgia

Fibromyalgia is a chronic condition affecting between 2% and 6% of the global population, characterized by widespread, persistent pain often associated with fatigue, sleep disturbances, cognitive difficulties and affective symptoms. Despite its high prevalence—particularly among women—the mechanisms contributing to the development and persistence of the disease are not yet fully understood.

≈